Who Does What? Understanding MDA’s Four Establishment Roles
The regulatory framework for medical devices is inherently complex. The following table offers an overview of four key establishment roles regulated by the Medical Device Authority (MDA) in Malaysia. It provides a structured, high‑level understanding of their responsibilities, activities, and compliance obligations, serving as a foundation before examining detailed requirements. Manufacturer Authorized Representative Importer Distributor Who is it? Person/company manufacturing the medical device Malaysian representative appointed by a foreign manufacturer Person/company appointed by AR to import devices Person/company distributing devices in Malaysia Establishment license Required Required Required Required Primary regulatory role Product manufacturer + registration Local authorized representative + registration Importation Distribution Certification requirement ISO 13485 GDPMD GDPMD GDPMD Medical device registration Yes Yes No No Manufactures device Yes No No No Registers device with MDA Yes Yes No No Imports device Not under Manufacturer-only licence Not under AR-only licence Yes No Distributes device Only devices it manufactures No No Yes Appoints / controls Distributor Importers & distributors for represented devices No No Global Rep is a professional regulatory affairs service provider dedicated to simplifying complex medical device regulatory procedures. We support companies seeking to enter the medical device sector, empowering them to achieve compliance and contribute meaningful value to the healthcare industry. We offer the following: Service Solutions GDPMD certification We guide your organisation in establishing and implementing an effective GDPMD system that strengthens medical device distribution practices, ensures regulatory compliance, and prepares your team for successful certification. Further insights: GDPMD System Setup, Certification, and Establishment License Application, and Foundations of Medical Device Compliance. ISO 13485 certification Our competent ISO 13485 consultants work closely with your team to develop a compliant and practical QMS aligned with ISO 13485 standard requirements. We guide your team in designing and implementing a robust system that supports device safety and effectiveness while enabling sustainable, long-term regulatory compliance. Further insights: ISO 13485 Certification: Your Gateway to Medical Device Market Access, and Foundations of Medical Device Compliance. Independent authorized representative We hold your medical device registration independently, giving you greater control and flexibility over your marketing strategy and distribution channels. This allows you to work with multiple local distributors without having to manage separate registration requests for the same product, while maintaining the confidentiality of your product information and preserving the freedom to adapt your market strategy as your business evolves. Further insights: What Does a Local Authorized Representative Do for Medical Devices?, and Medical Device Registration Holder Options: Local Authorized Representative vs Distributor. Pre-market device registration We provide end-to-end support for medical device registration, from device classification and technical documentation to regulatory submission, evaluation and obtaining pre-market clearance, helping you bring your medical devices to market efficiently and with confidence. Further insights: Navigating Malaysia’s Medical Device Registration Process, and Medical Device Classification in Malaysia. Registration maintenance We keep your medical device registrations current with ongoing support for renewals, amendments, changes and regulatory compliance throughout the product lifecycle. Post market surveillance We maintain your regulatory compliance after market entry through structured post-market surveillance, vigilance, incident reporting and corrective action support. You don’t need to navigate complex regulatory requirements on your own. Share your marketing plans with us, and we’ll take care of the regulatory pathway—identifying the requirements, preparing the necessary documentation and managing the process to help you achieve your market-entry goals and long term compliance.
Why Can’t One Establishment Rely on Another’s Conformity Assessment?
Nowadays, turning to AI platforms for answers has become a common practice. These systems generate responses by breaking user input into tokens, processing them through a neural network known as a transformer, and predicting the most probable next word step by step until a complete answer is formed. Unlike databases, they do not “know” facts directly but rely on statistical patterns learned from extensive training data. The accuracy of AI responses depends largely on the quality of the training data, the robustness of ongoing model maintenance, and how closely real-world context aligns with the conditions under which the model was trained. Inaccuracies often arise from poor data quality, model drift, or hallucinations—where the system produces information that sounds plausible but is not factually correct. On August 29, 2026, the following question was posted simultaneously to Microsoft Copilot, Google Gemini, and ChatGPT: “Why is an establishment not permitted to register a medical device through the verification pathway by leveraging the full conformity assessment already completed by another establishment?” The responses provided by these platforms are displayed below. Microsoft Copilot response: An establishment is not permitted to use the verification pathway for a medical device that has already been registered via full conformity assessment in Malaysia because the verification route is designed exclusively for devices with recognized international premarket clearance. Google Gemini response: 1. Distinct Regulatory Purpose & Sequence Verification Route: Designed solely as an expedited, reliant assessment pathway for devices that hold valid prior approvals from MDA-recognised foreign reference authorities (e.g., US FDA, EU CE, Singapore HSA, TGA Australia). The Conformity Assessment Body (CAB) relies on the foreign review to verify local compliance rather than doing a full evaluation. Full Conformity Assessment (FCA): Designed for devices without qualified foreign reference approvals or those undergoing complete local evaluation in Malaysia. Once a device goes through FCA, its regulatory baseline for Malaysia is already established via full domestic evaluation. Re-entering through a verification pathway intended for foreign market reliance contradicts the hierarchy of the regulatory routes. 2. Duplication & Invalid Reliance Logic The verification route exists to avoid double-evaluating clinical and technical data that another trusted foreign agency has already vetted. If a medical device has already undergone Full Conformity Assessment locally, Malaysia’s CAB and MDA have already performed the highest-tier, full-dossier evaluation. Attempting to use the verification route on an already FCA-assessed device would mean asking a CAB to “verify” the device using foreign evidence for a product that has already proven its compliance via Malaysia’s own complete assessment route. 3. Maintenance and Lifecycle Pathways (Re-registration) When a device registered via Full Conformity Assessment needs to be renewed, maintained, or updated: Renewals/Re-registration: The establishment must maintain the existing conformity assessment certificate (FCA) or use MDA’s official Re-registration Route (such as the automated re-registration in MeDC@St) rather than applying for a brand-new registration under a different evaluation route. Design/Device Changes: Modifications are handled through Change Notifications (CN) under the original FCA registration baseline, not by re-filing through the Verification Route. ChatGPT response: The key point is that the verification pathway is not simply an alternative registration route that an establishment may choose whenever a device is already registered in Malaysia. It is an abridged conformity-assessment pathway based on reliance on an approval from a recognised foreign regulatory authority or notified body. Under the current MDA/GD/0070 guidance, for initial registration by verification, the device must, among other things: have approval from at least one recognised regulatory authority or notified body; have the same design and intended purpose as the device approved by that authority/body; and satisfy the specified global safety requirements. Why a device already registered by full conformity assessment is different: If the device has already gone through full conformity assessment in Malaysia, its Malaysian registration is based on the Malaysian CAB’s own assessment of the manufacturer’s conformity evidence. The verification route is intended to leverage an existing recognised foreign assessment, rather than to provide a second, abbreviated route for an already-established Malaysian registration. In other words, the regulatory logic is: Foreign recognised approval → verification/abridged assessment → Malaysian registration; Rather than: Existing Malaysian full-assessment registration → switch retrospectively to verification. The MDA guidance does, however, expressly recognise verification for re-certification/re-registration of a device that was previously registered in Malaysia. It states that, for recertification, the device may have been assessed through either full conformity assessment or verification, provided that it has a valid registration certificate and meets the other eligibility conditions. So there is an important distinction: Situation Verification pathway Device is being registered for the first time and has an eligible foreign approval Potentially yes Device already registered in Malaysia following full conformity assessment, and you want to create another initial registration using verification Generally no Device is already registered in Malaysia and is undergoing eligible re-registration/recertification Potentially yes, subject to the verification criteria The underlying regulatory reason: Allowing an establishment to take an existing Malaysian registration that was obtained through full conformity assessment and simply re-register it through verification could effectively bypass the assessment pathway that was used to establish the device’s Malaysian conformity. Verification is based on regulatory reliance on an eligible external assessment; it is not designed as a mechanism for changing the conformity-assessment basis of an existing registration. This is also consistent with MDA’s current framework, where conformity assessment is a prerequisite to registration under Section 7 of the Medical Device Act 2012, and the level/type of assessment depends on the applicable pathway and risk. Confused? Let us clarify Our technical team has conducted a comprehensive review and analysis of the AIgenerated responses. We have determined that this particular question has not yet been sufficiently addressed or discussed within available online sources. Consequently, the AI platforms appear inadequately trained to provide a complete and reliable answer at this stage.Rather than leaving the matter unresolved, we invite you to join us as we dissect and examine the question together—step by step—towards a clearer understanding. “Why is an establishment not permitted to register a medical device through the
Innovation Meets Humanism
In 2026, we are proud to have the opportunity to contribute to Malaysia’s healthcare industry by donating a batch of personal protective gowns to the Academy for Silent Mentor Training Center (AFSM). AFSM is a non-profit NGO sustained through donations, sponsorships, and community support. Based in Malaysia, AFSM is a pioneering medical education institution founded in 2012 under Universiti Malaya and formalized in 2016. Built upon the altruistic foundation of voluntary body donation, AFSM blends surgical training with empathy, compassion, and humanistic values. Its vision is clear: to nurture healthcare professionals who are not only skillful but also deeply compassionate. At the heart of this mission is Professor Dr. Chin Kin Fah, Founding Chairman and Executive Director of AFSM. He pioneered the Silent Mentor program in Malaysia, advancing voluntary body donation for medical education, surgical training, and research. His leadership continues to emphasize the integration of empathy and compassion into healthcare practice. Through international partnerships, AFSM is shaping medical education worldwide, strengthening technical expertise while cultivating humanistic values among future doctors. Ready to Bring Innovation and Medical Device Registration Compliance Together? Global Rep is honored to support this vision. Beyond donations, our strength lies in medical device regulatory affairs. As a local authorized representative and regulatory affairs partner, we guide companies through pre-market requirements such as ISO 13485 certification and GDPMD certification, medical device registration to accelerate innovation entry, and post-market regulatory obligations to ensure sustainable business operations. Together, we can shape the future of Malaysia’s healthcare industry with both innovation and compassion.
Four Decades of Impact: Pinang Medical Supplies and the Evolution of Homecare
It was a great privilege to meet with Mr. Teh, the founder of Pinang Medical Supplies Sdn Bhd (PMS), on 6 August 2026 at Global Rep. PMS established in 1980 and headquartered in Penang, Malaysia, is a leading distributor and retailer of medical devices, disposables, and healthcare products. With over four decades of experience, PMS has built a strong presence across Malaysia and Singapore, operating branches in Kuala Lumpur, Melaka, Johor, Ipoh, and its retail arm, HomeCare Shop, which is recognized as Malaysia’s largest home care chain store. The company supplies a wide range of products including wheelchairs, orthopedic supports, posture care devices, pain management tools, elderly care solutions, incontinence products, and daily living aids, while also distributing exclusive international brands such as Obena, OppO, Backjoy, Karma, Etac etc. PMS imports from multiple countries and procures locally, serving hospitals, clinics, pharmacies, and direct consumers, and has expanded into e-commerce through its own online store and platforms like Shopee. Renowned as a trusted market leader, PMS is committed to improving quality of life by making healthcare and wellness solutions accessible, affordable, and reliable. We conducted a comprehensive review of current trends, challenges, and the future outlook in homecare product supply, homecare services, nursing homes, and hospitals. The session with Mr. Teh was truly eye‑opening, and we were deeply impressed by his foresight regarding the homecare industry. We are honored to have gained insights into his vision for advancing homecare across multiple dimensions to benefit the community, as well as his strategy to support and nurture younger generations in building sustainable homecare businesses.We are pleased to extend to PMS our medical device registration services, enabling Global Rep to add value to a homecare industry that is rapidly evolving into a technology-driven, patient-centred ecosystem, fuelled by strong growth in Malaysia and globally due to aging populations, demand for aging-in-place solutions, and the integration of AI, remote monitoring, and personalized care. According to Coherent Market Insights, the global homecare market in 2026 is valued at over USD 650 billion, with medical equipment and elderly care driving the largest shares. North America leads with approximately 35% of the market, while Asia Pacific—including Malaysia—is rapidly expanding with a 25% share, fuelled by aging populations and the growing demand for aging-in-place solutions. The homecare business is both lucrative and future-proof, particularly in Malaysia where demographic trends and regulatory clarity create strong opportunities. Success in this sector depends on embracing technology adoption, delivering community-focused services, and maintaining strict compliance — especially in medical device registration and post-market surveillance. Most homecare products fall within the definition of medical devices. For example, wheelchairs provide mobility for individuals with disabilities or medical conditions; limb supports stabilize, align, or support weakened or injured body parts, serving a therapeutic role in rehabilitation, pain reduction, and mobility improvement; and posture care products help prevent, correct, or support musculoskeletal alignment. In line with the Malaysia Medical Device Act 2012, any establishment intending to market medical devices must ensure that the devices are duly registered prior to commercialization. Looking for a Reliable Local Authorized Representative or a Regulatory Affairs Support for Medical Devices? At Global Rep, we specialize in medical device regulatory affairs, empowering businesses by managing the full spectrum of regulatory requirements — from medical device registration and pre-market obligations to post-market changes and surveillance. As your trusted local authorized representative for medical device and regulatory affairs support, we allow our partners to stay compliant while focusing on what they do best: innovating, growing, and delivering value to the communities they serve.
Malaysia: Your Gateway to ASEAN Healthcare Growth
Leveraging Malaysia as a Strategic Investment Platform for Regional Expansion, Innovation and Healthcare Excellence Global Rep was honored to participate in the webinar organized by Informa Markets on 5 Aug 2026, where government representatives and industry leaders shared valuable insights on how Malaysia’s robust infrastructure, highly skilled workforce, and strong regional connectivity are enabling businesses to expand their presence and unlock new opportunities across one of the world’s fastest-growing healthcare markets. Malaysia stands out as a prime destination for healthcare investment in ASEAN. With a robust healthcare market, strong infrastructure, and political stability, it offers both affordability and innovation. Its medical tourism sector continues to expand, supported by advanced facilities and the Malaysia Healthcare Travel Council (MHTC). Strategic initiatives like the World Health Expo Kuala Lumpur further connect investors to regional opportunities, making Malaysia a thriving hub for healthcare growth and partnerships. Overview The webinar discussed Malaysia’s strategic role in ASEAN healthcare growth. Mr. Abdul Halim Muhammad Shariff (Abdul Halim), Deputy Director of the Life Science and Lifestyle Section at the Malaysia External Trade Development Corporation (MATRADE), highlighted Malaysia’s healthcare ecosystem, including its $21.6 billion healthcare spending and 34.4 million population. Mr. Lokman Izam Abd Aziz (Lokman), Vice President of Marketing & Communications emphasized Malaysia’s medical tourism potential, noting a 101% revenue increase since 2019 and a $10,000 health screening costing under $800. Ms. Nisha Tamzamrat (Nisha), Source of Asia (SOA), showcased the World Health Expo Kuala Lumpur, expecting 450 exhibitors and 13,000 attendees in 2027. Ms. Rathanesh Ramasundram (Rathanesh), Head of Healthcare & Life Sciences, Frost & Sullivan, identified key investment themes: preventive healthcare, chronic disease management, elderly care, digital health, diagnostics, and medical tourism, predicting a 15% annual growth in healthcare travelers. Abdul Halim highlighted Malaysia’s unique position in the ASEAN healthcare market, emphasizing its comprehensive healthcare ecosystem, including manufacturing and clinical research. He noted Malaysia’s high healthcare expenditure per capita, which supports investment in new technologies and treatments. Lokman discussed Malaysia’s attractiveness for healthcare business and medical travelers, citing its unique selling propositions and investment opportunities across various healthcare sectors. He also mentioned the role of Malaysia Healthcare Travel Council (MHTC) in facilitating processes for international patients and investors. The session concluded with a call for further engagement and partnerships within the ASEAN healthcare market. Outline Abdul Halim Mohamed Shariff’s Presentation on Malaysia as a Strategic Investment Platform Abdul Halim introduces MATRADE and its role in promoting Malaysian companies internationally. Abdul Halim discusses the growth of the global healthcare industry, predicting a $11.3 trillion market by 2030. He highlights the challenges faced by the global healthcare industry, including lifestyle changes, aging population, and technological gaps. Abdul Halim emphasizes Malaysia’s strategic location and advantages, such as political stability and connectivity, making it a hub for the healthcare industry. Abdul Halim explains Malaysia’s two-tier healthcare system: public and private, with the private sector driven by insurance and healthcare tourism. He highlights the growth of private hospitals and the increasing demand for healthcare services in Malaysia. Abdul Halim discusses the opportunities in the healthcare industry, including preventive lifestyle services and aged care living. He mentions the government’s focus on developing the healthcare product-related manufacturing and reforming the healthcare services. Lokman Izam Abd Aziz’s Presentation on Medical Tourism Excellence in Malaysia Lokman introduces the Malaysia Healthcare Travel Council (MHTC) and its role in positioning Malaysia as a leading healthcare travel destination. Lokman explains the patient journey in medical tourism and the importance of trust, partnerships, and capital in the industry. He highlights the global growth of the medical tourism market and Malaysia’s strong growth in the sector. Lokman discusses the multiplier effect of medical tourism on various industries and the importance of nurturing trust among patients. Nisha Tamzamrat’s Presentation on Connecting to ASEAN Healthcare Business Nisha introduces World Health Expo Kuala Lumpur (WHX Kuala Lumpur) and its role in connecting international business with opportunities across the ASEAN healthcare market. She highlights the ASEAN market’s potential, with a combined healthcare expenditure of $270 billion in 2026. Nisha discusses the advantages of Malaysia as a medical hub, including its strategic location, technology adoption, and competitive costs. She outlines the features of WHX Kuala Lumpur, including exhibitions, conferences, and business matching platforms. Rathanesh Ramasundram’s Presentation on Malaysia’s Private Healthcare Advantage Rathanesh discusses Malaysia’s position as a platform for ASEAN healthcare growth, emphasizing its strong ecosystem and underlying economics. He highlights the demographic changes in Malaysia, with the country expected to reach aged nation status by 2030. Rathanesh explains the opportunities in the private healthcare sector, including preventive healthcare, chronic disease management, and elderly care. He emphasizes the importance of investing in asset-light, recurring revenue models and moving beyond traditional hospital beds. Malaysia’s Unique Healthcare Ecosystem Abdul Halim Mohamed Shariff highlights that while Malaysia has a smaller population compared to Indonesia and the Philippines, it offers a unique proposition in the healthcare ecosystem. Malaysia is established in healthcare services, manufacturing, and clinical research, with the latter led by Clinical Research Malaysia. The country’s demographic profile attracts a significant number of clinical studies, enhancing its research capabilities. Abdul Halim notes that Malaysia’s high healthcare expenditure per capita, though lower than Singapore and Brunei, indicates affordability for good healthcare services and new technologies. Malaysia’s high healthcare expenditure supports the investment in new technologies and treatments, making it an attractive destination for healthcare investments. Healthcare Expenditure and Investment Opportunities Abdul Halim emphasizes that Malaysia’s high healthcare expenditure per capita complements the surrounding region, providing support through its healthcare services. The ecosystem in Malaysia extends healthcare services to the region, supporting health tourism and the overall healthcare needs of the ASEAN region. Mariyah invites Lokman Izam Abd Aziz to share his thoughts on what makes Malaysia an attractive destination for healthcare business and medical travelers. Lokman Izam Abd Aziz approaches the question from two perspectives: the unique selling propositions of Malaysia and the investment opportunities for investors. He highlights the importance of the overall ecosystem, from pre-patient care to post-patient care, and the role of MHC in easing
Celebrating Success at APHM 2026
APHM International Healthcare Exhibition 2026 (APHM 2026) marked the 32nd edition of Malaysia’s premier private healthcare event, held from July 28–30, 2026 at the Kuala Lumpur Convention Centre. With the theme “From Volume to Value: Measuring What Matters in Healthcare Performance,” the conference brought together hospital leaders, regulators, insurers, and technology innovators to explore healthcare transformation, patient safety, sustainability, and medicolegal issues. Beyond the insightful presentations by distinguished speakers, APHM 2026 showcased the strength of the healthcare industry with more than 150 exhibitors from Malaysia, ASEAN, and across the globe. This made it one of the largest healthcare trade shows in the region, featuring innovations in hospital equipment, digital health solutions, sustainability initiatives, and patient safety technologies. Global Rep was honoured to be part of this distinguished event, engaging with trusted partners and companies that continue to place their confidence in us. The exhibition also provided a valuable opportunity to meet customers face-to-face, share updates on medical device registration in Malaysia, and provide timely answers that help accelerate ongoing projects. A highlight of our participation was an in-person meeting with our potential partner from China, the Technical Consultancy Center (TCC). Renowned for their expertise in medical device regulatory registration and global market access, TCC brings deep knowledge to the table. Our discussion was open, sincere, and forwardlooking — focusing on collaboration preferences and strategic plans within ASEAN. We are excited to build on this strong foundation and move toward impactful collaborations in the near future. Global Rep is committed to continuously enhancing its services, strengthening its position in the market, and delivering valuable solutions that empower customers across the region. We warmly invite you to connect with us — let’s grow bigger, stronger, and achieve success together. Ready to Bring Your Medical Device to Malaysia and ASEAN? Partner with Global Rep for expert medical device regulatory affairs, medical device registration and faster market access. Our experienced team will guide you through every stage of the regulatory process. Let’s turn your expansion plans into progress.